Artificial intelligence-based detection of FGFR3 mutational status directly from routine histology in bladder cancer: A possible preselection for molecular testing?. Eur. Urol. Focus, (8)2:472--479, Elsevier BV, March 2022. [PUMA: Artificial intelligence; learning; therapy for Deep mutations; Bladder cancer; Molecular fibroblast receptor testing growth factor FGFR3]